United States Lifestyle Drugs Market Report 2017

August 2017 | 114 pages | ID: U0B1CEFB74DEN
QYResearch

Abstracts

In this report, the United States Lifestyle Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Lifestyle Drugs in these regions, from 2012 to 2022 (forecast).

United States Lifestyle Drugs market competition by top manufacturers/players, with Lifestyle Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Allergan
• BMS
• Eli Lilly
• Pfizer
• Acerus Pharmaceuticals
• Alkermes
• Amorepacific
• AndroScience
• Anterios
• AstraZeneca
• Avanir Pharmaceuticals
• Avolynt
• Celtaxsys
• Cerecor

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Tablets
• Capsules
• Injections

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Lifestyle Drugs for each application, including

• Depression
• Dermatology
• Sexual dysfunction
• Obesity

Contents

United States Lifestyle Drugs Market Report 2017

1 LIFESTYLE DRUGS OVERVIEW

1.1 Product Overview and Scope of Lifestyle Drugs
1.2 Classification of Lifestyle Drugs by Product Category
  1.2.1 United States Lifestyle Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Lifestyle Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Tablets
  1.2.4 Capsules
  1.2.5 Injections
1.3 United States Lifestyle Drugs Market by Application/End Users
  1.3.1 United States Lifestyle Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Depression
  1.3.3 Dermatology
  1.3.4 Sexual dysfunction
  1.3.5 Obesity
1.4 United States Lifestyle Drugs Market by Region
  1.4.1 United States Lifestyle Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Lifestyle Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Lifestyle Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Lifestyle Drugs Status and Prospect (2012-2022)
  1.4.5 New England Lifestyle Drugs Status and Prospect (2012-2022)
  1.4.6 The South Lifestyle Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Lifestyle Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Lifestyle Drugs (2012-2022)
  1.5.1 United States Lifestyle Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Lifestyle Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES LIFESTYLE DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Lifestyle Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Lifestyle Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Lifestyle Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Lifestyle Drugs Market Competitive Situation and Trends
  2.4.1 United States Lifestyle Drugs Market Concentration Rate
  2.4.2 United States Lifestyle Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Lifestyle Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES LIFESTYLE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Lifestyle Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Lifestyle Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Lifestyle Drugs Price by Region (2012-2017)

4 UNITED STATES LIFESTYLE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Lifestyle Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Lifestyle Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Lifestyle Drugs Price by Type (2012-2017)
4.4 United States Lifestyle Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES LIFESTYLE DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Lifestyle Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Lifestyle Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES LIFESTYLE DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Allergan
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Lifestyle Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Allergan Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 BMS
  6.2.2 Lifestyle Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 BMS Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly
  6.3.2 Lifestyle Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lilly Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Lifestyle Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Acerus Pharmaceuticals
  6.5.2 Lifestyle Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Acerus Pharmaceuticals Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Alkermes
  6.6.2 Lifestyle Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Alkermes Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Amorepacific
  6.7.2 Lifestyle Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Amorepacific Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 AndroScience
  6.8.2 Lifestyle Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 AndroScience Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Anterios
  6.9.2 Lifestyle Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Anterios Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 AstraZeneca
  6.10.2 Lifestyle Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AstraZeneca Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Avanir Pharmaceuticals
6.12 Avolynt
6.13 Celtaxsys
6.14 Cerecor

7 LIFESTYLE DRUGS MANUFACTURING COST ANALYSIS

7.1 Lifestyle Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Lifestyle Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Lifestyle Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Lifestyle Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LIFESTYLE DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Lifestyle Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Lifestyle Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Lifestyle Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Lifestyle Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Lifestyle Drugs
Figure United States Lifestyle Drugs Market Size (K Units) by Type (2012-2022)
Figure United States Lifestyle Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablets Product Picture
Figure Capsules Product Picture
Figure Injections Product Picture
Figure United States Lifestyle Drugs Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Lifestyle Drugs by Application in 2016
Figure Depression Examples
Figure Dermatology Examples
Figure Sexual dysfunction Examples
Figure Obesity Examples
Figure United States Lifestyle Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Lifestyle Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Lifestyle Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Lifestyle Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Lifestyle Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Lifestyle Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Lifestyle Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2022)
Figure United States Lifestyle Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Lifestyle Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Lifestyle Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Lifestyle Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Lifestyle Drugs Sales Share by Players/Suppliers
Figure 2017 United States Lifestyle Drugs Sales Share by Players/Suppliers
Figure United States Lifestyle Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Lifestyle Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Lifestyle Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Lifestyle Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Lifestyle Drugs Revenue Share by Players/Suppliers
Table United States Market Lifestyle Drugs Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Lifestyle Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Lifestyle Drugs Market Share of Top 3 Players/Suppliers
Figure United States Lifestyle Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Lifestyle Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Lifestyle Drugs Product Category
Table United States Lifestyle Drugs Sales (K Units) by Region (2012-2017)
Table United States Lifestyle Drugs Sales Share by Region (2012-2017)
Figure United States Lifestyle Drugs Sales Share by Region (2012-2017)
Figure United States Lifestyle Drugs Sales Market Share by Region in 2016
Table United States Lifestyle Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Lifestyle Drugs Revenue Share by Region (2012-2017)
Figure United States Lifestyle Drugs Revenue Market Share by Region (2012-2017)
Figure United States Lifestyle Drugs Revenue Market Share by Region in 2016
Table United States Lifestyle Drugs Price (USD/Unit) by Region (2012-2017)
Table United States Lifestyle Drugs Sales (K Units) by Type (2012-2017)
Table United States Lifestyle Drugs Sales Share by Type (2012-2017)
Figure United States Lifestyle Drugs Sales Share by Type (2012-2017)
Figure United States Lifestyle Drugs Sales Market Share by Type in 2016
Table United States Lifestyle Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Lifestyle Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Lifestyle Drugs by Type (2012-2017)
Figure Revenue Market Share of Lifestyle Drugs by Type in 2016
Table United States Lifestyle Drugs Price (USD/Unit) by Types (2012-2017)
Figure United States Lifestyle Drugs Sales Growth Rate by Type (2012-2017)
Table United States Lifestyle Drugs Sales (K Units) by Application (2012-2017)
Table United States Lifestyle Drugs Sales Market Share by Application (2012-2017)
Figure United States Lifestyle Drugs Sales Market Share by Application (2012-2017)
Figure United States Lifestyle Drugs Sales Market Share by Application in 2016
Table United States Lifestyle Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Lifestyle Drugs Sales Growth Rate by Application (2012-2017)
Table Allergan Basic Information List
Table Allergan Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Lifestyle Drugs Sales Growth Rate (2012-2017)
Figure Allergan Lifestyle Drugs Sales Market Share in United States (2012-2017)
Figure Allergan Lifestyle Drugs Revenue Market Share in United States (2012-2017)
Table BMS Basic Information List
Table BMS Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BMS Lifestyle Drugs Sales Growth Rate (2012-2017)
Figure BMS Lifestyle Drugs Sales Market Share in United States (2012-2017)
Figure BMS Lifestyle Drugs Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Lifestyle Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly Lifestyle Drugs Sales Market Share in United States (2012-2017)
Figure Eli Lilly Lifestyle Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Lifestyle Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Lifestyle Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Lifestyle Drugs Revenue Market Share in United States (2012-2017)
Table Acerus Pharmaceuticals Basic Information List
Table Acerus Pharmaceuticals Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Acerus Pharmaceuticals Lifestyle Drugs Sales Growth Rate (2012-2017)
Figure Acerus Pharmaceuticals Lifestyle Drugs Sales Market Share in United States (2012-2017)
Figure Acerus Pharmaceuticals Lifestyle Drugs Revenue Market Share in United States (2012-2017)
Table Alkermes Basic Information List
Table Alkermes Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alkermes Lifestyle Drugs Sales Growth Rate (2012-2017)
Figure Alkermes Lifestyle Drugs Sales Market Share in United States (2012-2017)
Figure Alkermes Lifestyle Drugs Revenue Market Share in United States (2012-2017)
Table Amorepacific Basic Information List
Table Amorepacific Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amorepacific Lifestyle Drugs Sales Growth Rate (2012-2017)
Figure Amorepacific Lifestyle Drugs Sales Market Share in United States (2012-2017)
Figure Amorepacific Lifestyle Drugs Revenue Market Share in United States (2012-2017)
Table AndroScience Basic Information List
Table AndroScience Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AndroScience Lifestyle Drugs Sales Growth Rate (2012-2017)
Figure AndroScience Lifestyle Drugs Sales Market Share in United States (2012-2017)
Figure AndroScience Lifestyle Drugs Revenue Market Share in United States (2012-2017)
Table Anterios Basic Information List
Table Anterios Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Anterios Lifestyle Drugs Sales Growth Rate (2012-2017)
Figure Anterios Lifestyle Drugs Sales Market Share in United States (2012-2017)
Figure Anterios Lifestyle Drugs Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Lifestyle Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Lifestyle Drugs Sales Market Share in United States (2012-2017)
Figure AstraZeneca Lifestyle Drugs Revenue Market Share in United States (2012-2017)
Table Avanir Pharmaceuticals Basic Information List
Table Avolynt Basic Information List
Table Celtaxsys Basic Information List
Table Cerecor Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Lifestyle Drugs
Figure Manufacturing Process Analysis of Lifestyle Drugs
Figure Lifestyle Drugs Industrial Chain Analysis
Table Raw Materials Sources of Lifestyle Drugs Major Players/Suppliers in 2016
Table Major Buyers of Lifestyle Drugs
Table Distributors/Traders List
Figure United States Lifestyle Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Lifestyle Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Lifestyle Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Lifestyle Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Lifestyle Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Lifestyle Drugs Sales Volume (K Units) Forecast by Type in 2022
Table United States Lifestyle Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Lifestyle Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Lifestyle Drugs Sales Volume (K Units) Forecast by Application in 2022
Table United States Lifestyle Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Lifestyle Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Lifestyle Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Lifestyle Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources